---
title: "EMPOWER CAD all-female IVL trial completes enrolment"
date: "2024-10-28T20:42:38.000Z"
publishedDate: "28 octobre 2024"
summary: "Shockwave Medical has announced the completion of enrolment in EMPOWER CAD, the first prospective all-female study of percutaneous coronary intervention (PCI) in complex calcific disease. The study is seeking to confirm the benefits of coronary intravascular lithotripsy (IVL) in female patients with calcified lesions in a post-market, real-world, all-comers population."
importance: ""
sourceUrl: "https://cardiovascularnews.com/empower-cad-all-female-ivl-trial-completes-enrolment/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-10-28-empower-cad-all-female-ivl-trial-completes-enrolment"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/10/Shockwave-demo.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/empower-cad-all-female-ivl-trial-completes-enrolment/"
---

![EMPOWER CAD all-female IVL trial completes enrolment](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/10/Shockwave-demo.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/empower-cad-all-female-ivl-trial-completes-enrolment/*

## L’essentiel

Shockwave Medical has announced the completion of enrolment in EMPOWER CAD, the first prospective all-female study of percutaneous coronary intervention (PCI) in complex calcific disease. The study is seeking to confirm the benefits of coronary intravascular lithotripsy (IVL) in female patients with calcified lesions in a post-market, real-world, all-comers population.

## Lien source

https://cardiovascularnews.com/empower-cad-all-female-ivl-trial-completes-enrolment/
